Assessing MRI Techniques for Diagnosing Bladder Cancer
Validity of Parametric MRI Using VIRAD Scoring in the Diagnosis of Cancer Bladder
NA · Assiut University · NCT05783271
This study is testing if two different types of MRI scans can help doctors better diagnose invasive bladder cancer in patients who are suspected of having it.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 58 (estimated) |
| Sex | All |
| Sponsor | Assiut University (other) |
| Locations | 1 site (Asyut, Assuit) |
| Trial ID | NCT05783271 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of biparametric and multiparametric MRI in diagnosing invasive bladder cancer using the VIRAD scoring system. Bladder cancer is a prevalent condition that varies in aggressiveness, making accurate diagnosis crucial for determining appropriate treatment. The study will involve patients suspected of having bladder cancer based on clinical and imaging assessments. By comparing MRI results with established diagnostic methods, the study seeks to improve the accuracy and validity of bladder cancer diagnoses.
Who should consider this trial
Good fit: Ideal candidates include individuals of any age and gender who are suspected of having bladder cancer based on clinical and imaging evaluations.
Not a fit: Patients with high renal chemistry or those who have contraindications to MRI, such as pacemakers or cochlear implants, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnostic accuracy for bladder cancer, leading to better treatment decisions and outcomes for patients.
How similar studies have performed: While the use of MRI in bladder cancer diagnosis is established, the specific application of VIRAD scoring in this context is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 58 cases of patients who suspected to have cancer urinary bladder by clinical, histopathological examination and radiological imaging. All age groups . Both sex Exclusion Criteria: patient with high renal chemistry. Patient with contraindications to MRI as pacemaker and cochlear implants. \-
Where this trial is running
Asyut, Assuit
- Assuit university — Asyut, Assuit, Egypt (RECRUITING)
Study contacts
- Principal investigator: Hassan A.Abolella, Proff — Newvalley University
- Study coordinator: Hassan Megally, proff
- Email: hasanibrahim48@yahoo.com
- Phone: 01006209584
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Bladder Cancer